BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16306381)

  • 1. Single nucleotide polymorphisms in the peroxisome proliferator-activated receptor delta gene are associated with skeletal muscle glucose uptake.
    Vänttinen M; Nuutila P; Kuulasmaa T; Pihlajamäki J; Hällsten K; Virtanen KA; Lautamäki R; Peltoniemi P; Takala T; Viljanen AP; Knuuti J; Laakso M
    Diabetes; 2005 Dec; 54(12):3587-91. PubMed ID: 16306381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Andrulionyte L; Peltola P; Chiasson JL; Laakso M;
    Diabetes; 2006 Jul; 55(7):2148-52. PubMed ID: 16804087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention.
    Stefan N; Thamer C; Staiger H; Machicao F; Machann J; Schick F; Venter C; Niess A; Laakso M; Fritsche A; Häring HU
    J Clin Endocrinol Metab; 2007 May; 92(5):1827-33. PubMed ID: 17327385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the Ala12 allele of the peroxisome proliferator-activated receptor-gamma2 gene on skeletal muscle glucose uptake depends on obesity: a positron emission tomography study.
    Vänttinen M; Nuutila P; Pihlajamäki J; Hällsten K; Virtanen KA; Lautamäki R; Peltoniemi P; Kemppainen J; Takala T; Viljanen AP; Knuuti J; Laakso M
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4249-54. PubMed ID: 15855261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans.
    Staiger H; Haas C; Machann J; Werner R; Weisser M; Schick F; Machicao F; Stefan N; Fritsche A; Häring HU
    Diabetes; 2009 Mar; 58(3):579-89. PubMed ID: 19074989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between hypertension and the peroxisome proliferator-activated receptor-δ (PPARD) gene rs7770619 C>T polymorphism in a Korean population.
    Kim M; Kim M; Yoo HJ; Shon J; Lee JH
    Hum Genomics; 2018 Jun; 12(1):28. PubMed ID: 29914579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro responsiveness of human muscle cell peroxisome proliferator-activated receptor δ reflects donors' insulin sensitivity in vivo.
    Ordelheide AM; Heni M; Thamer C; Machicao F; Fritsche A; Stefan N; Häring HU; Staiger H
    Eur J Clin Invest; 2011 Dec; 41(12):1323-9. PubMed ID: 21615395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action.
    Loviscach M; Rehman N; Carter L; Mudaliar S; Mohadeen P; Ciaraldi TP; Veerkamp JH; Henry RR
    Diabetologia; 2000 Mar; 43(3):304-11. PubMed ID: 10768091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and liver: a positron emission tomography study.
    Honka MJ; Latva-Rasku A; Bucci M; Virtanen KA; Hannukainen JC; Kalliokoski KK; Nuutila P
    Eur J Endocrinol; 2018 May; 178(5):523-531. PubMed ID: 29535167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new, highly selective murine peroxisome proliferator-activated receptor δ agonist increases responsiveness to thermogenic stimuli and glucose uptake in skeletal muscle in obese mice.
    Ngala RA; Stocker CJ; Roy AG; Hislop D; Wargent E; Bell R; Hassall DG; Harling JD; Billin AN; Willson TM; Arch JR; Cawthorne MA
    Diabetes Obes Metab; 2011 May; 13(5):455-64. PubMed ID: 21272187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early postnatal oestradiol exposure causes insulin resistance and signs of inflammation in circulation and skeletal muscle.
    Alexanderson C; Eriksson E; Stener-Victorin E; Lönn M; Holmäng A
    J Endocrinol; 2009 Apr; 201(1):49-58. PubMed ID: 19193715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor (PPAR) delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects.
    Hu C; Jia W; Fang Q; Zhang R; Wang C; Lu J; Xiang K
    Diabet Med; 2006 Dec; 23(12):1307-12. PubMed ID: 17116180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in PPARD determine the change in body composition during lifestyle intervention: a whole-body magnetic resonance study.
    Thamer C; Machann J; Stefan N; Schäfer SA; Machicao F; Staiger H; Laakso M; Böttcher M; Claussen C; Schick F; Fritsche A; Haring HU
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1497-500. PubMed ID: 18252792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor (PPAR) isoforms are differentially expressed in peri-implantation porcine conceptuses.
    Blitek A; Szymanska M
    Theriogenology; 2017 Oct; 101():53-61. PubMed ID: 28708516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor delta (PPARD) genetic variation and type 2 diabetes in middle-aged Chinese women.
    Villegas R; Williams S; Gao Y; Cai Q; Li H; Elasy T; Cai H; Edwards T; Xiang YB; Zheng W; Long J; Ou Shu X
    Ann Hum Genet; 2011 Sep; 75(5):621-9. PubMed ID: 21834910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise training favors increased insulin-stimulated glucose uptake in skeletal muscle in contrast to adipose tissue: a randomized study using FDG PET imaging.
    Reichkendler MH; Auerbach P; Rosenkilde M; Christensen AN; Holm S; Petersen MB; Lagerberg A; Larsson HB; Rostrup E; Mosbech TH; Sjödin A; Kjaer A; Ploug T; Hoejgaard L; Stallknecht B
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E496-506. PubMed ID: 23800880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in the peroxisome proliferator-activated receptor delta gene in relation to common metabolic traits in 7,495 middle-aged white people.
    Grarup N; Albrechtsen A; Ek J; Borch-Johnsen K; Jørgensen T; Schmitz O; Hansen T; Pedersen O
    Diabetologia; 2007 Jun; 50(6):1201-8. PubMed ID: 17431579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise.
    Kannisto K; Chibalin A; Glinghammar B; Zierath JR; Hamsten A; Ehrenborg E
    Int J Mol Med; 2006 Jan; 17(1):45-52. PubMed ID: 16328010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
    Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
    Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor (PPAR) activation induces tissue-specific effects on fatty acid uptake and metabolism in vivo--a study using the novel PPARalpha/gamma agonist tesaglitazar.
    Hegarty BD; Furler SM; Oakes ND; Kraegen EW; Cooney GJ
    Endocrinology; 2004 Jul; 145(7):3158-64. PubMed ID: 15059948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.